Cannabis Law Report

JANUARY 23, 2023

VF1883 Pharmaceuticals, a medical cannabis producer based in Benavente, has been declared insolvent by the Santarém Court. The insolvency declaration judgment, requested by one of the company’s more than 80 creditors, was handed down on 23 November 2022 and has now become final, in January 2023.

Pharmaceutical 52

Pharmaceutical Access Cannabis Compliance 52

The Fresh Toast

MARCH 20, 2019

Consumers Are Replacing Pharmaceuticals With Medical Marijuana In recent years, certain states that have medical and/or recreational cannabis programs in place have experienced decreases in the number of opioid overdoses. The post Consumers Are Replacing Pharmaceuticals With Medical Marijuana appeared first on The Fresh Toast.

Pharmaceutical 106

Pharmaceutical Marijuana Programs Recreational 106

Cannabis Law Report

OCTOBER 25, 2022

The transformative deal is expected to connect Flora Growth’s Colombian-grown cannabis directly with German-based pharmaceutical and medical cannabis distribution. The deal would establish a foothold in Germany for medical cannabis sales across 1,200 pharmacies and the distribution […].

Pharmaceutical 59

Pharmaceutical Cannabis 59

Cannabis Law Report

JANUARY 17, 2023

Celadon Pharmaceuticals PLC shares rose on Monday after the company said that its Midlands facility has been registered for the good manufacturing practice standard by the U.K.’s ’s health watchdog for the production of its medicinal cannabis. The UK-based pharmaceutical company focused on […].

Pharmaceutical 52

Pharmaceutical Medicine Cannabis 52

Cannabis Law Report

MAY 26, 2023

Multinational operator to supply pharmaceutical-grade CBD extract for European patients TOCANCIPÁ, Colombia, May 25, 2023 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc.

Pharmaceutical 52

Pharmaceutical Extraction Medicine CBD 52

Cannabis Law Report

MARCH 26, 2022

Construction has begun on a medical cannabis manufacturing facility which will create more than 100 jobs. Jazz Pharmaceuticals is investing £75m in a plant based at Kent Science Park (KSP) in Sittingbourne, Kent.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

Cannabis Law Report

OCTOBER 20, 2020

Here’s a quick blurb……… The rapid growth of cannabis-based medicines is becoming a significant disruptor of the global pharmaceutical industry, but the point of … Read More. The post Prohibition Partners (UK) Publish "The Pharmaceutical Cannabis Report" first appeared on Cannabis Law Report.

Pharmaceutical 59

Pharmaceutical Medicine Cannabis Law 59

Cannabis Law Report

MAY 12, 2021

BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq: MYMD), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing… Read More.

Pharmaceutical 75

Pharmaceutical Business 75

Cannabis Law Report

FEBRUARY 3, 2021

The post Jazz Pharmaceuticals Pick Up GW Pharma For A Cool $7.2 billion first appeared on Cannabis Law Report. For those of you living under a rock here is the news. We thought we better report it along with… Read More.

Pharmaceutical 98

Pharmaceutical Law Cannabis 98

Cannabis Law Report

MAY 12, 2020

GW Pharmaceuticals lost $8 million in its latest quarter – an improvement over the previous three-month period – but the United Kingdom-based medical cannabinoid company … Read More.

Pharmaceutical 98

Pharmaceutical Cannabinoids 98

Cannabis Law Report

DECEMBER 12, 2020

Clever Leaves expands global capabilities and development of market specific pharmaceutical products. The post Clever Leaves Successfully Delivers First Shipment of EU GMP certified Cannabis derived Pharmaceuticals from Colombia to Germany first appeared on Cannabis Law Report. NEW YORK, Dec.

Pharmaceutical 84

Pharmaceutical Law Cannabis 84

Cannabis Law Report

FEBRUARY 3, 2021

The post February 4 2021: Jim Cramer on Jazz Pharmaceuticals buying GW Pharma for $7.2 billion first appeared on Cannabis Law Report. … Read More.

Pharmaceutical 98

Pharmaceutical Law Cannabis 98

Cannabis Law Report

JUNE 17, 2021

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) raised its full-year 2021 financial guidance based on the acquisition of GW Pharmaceuticals, which was bought on May 5, 2021. regulatory approval, and our new cannabinoid research platform,” said Renée Galá, the chief financial officer of Jazz Pharmaceuticals.

Pharmaceutical 108

Pharmaceutical Clinical Trials Therapy Programs 108

Cannabis Law Report

NOVEMBER 23, 2020

22 Nov – Blurb… Since 2019, Medicinal Cannabis Clinics has facilitated over 4,000 medical consultations with pre-screened eligible patients and has shown continued month-on-month growth.… The post MGC Pharmaceuticals acquires Australian telehealth platform Medicinal Cannabis Clinics first appeared on Cannabis Law Report.

Pharmaceutical 59

Pharmaceutical Medicine Patients Cannabis 59

Cannabis Law Report

FEBRUARY 3, 2021

The post February 4 2021: Jazz Pharmaceuticals buys GW Pharma for $7.2 billion first appeared on Cannabis Law Report. … Read More.

Pharmaceutical 85

Pharmaceutical Law Cannabis 85

Cannabis Law Report

JUNE 7, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms.

Pharmaceutical 79

Pharmaceutical Clinical Trials CBD Banking 79

Cannabis Law Report

MARCH 20, 2021

Algernon Pharmaceuticals Inc. CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (“Algernon”), a clinical stage pharmaceutical development company, is pleased to announce… Read More.

Pharmaceutical 98

Pharmaceutical Programs Cannabis 98

Cannabis Law Report

FEBRUARY 23, 2022

(TSX: LABS) (OTCQX: MEDIF ) (FSE: MLZ) (“MediPharm” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce it has completed a US FDA DMF for pure natural CBD API. The DMF will enable MediPharm to supply approved API to pharmaceutical companies currently conducting late-stage research.

Pharmaceutical 52

Pharmaceutical Research and Development Extraction Cannabinoids 52

SpeedWeed

SEPTEMBER 3, 2021

Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025 – Cannabis Business Executive – Cannabis and Marijuana industry news. The post Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 View original article.

Pharmaceutical 55

Pharmaceutical Business Cannabis Marijuana 55

Cannabis Law Report

DECEMBER 15, 2021

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

Pharmaceutical 52

Pharmaceutical Cannabinoids Business Extraction 52

Cannabis Law Report

APRIL 13, 2021

Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has appointed ex-GW Pharmaceuticals CFO… Read More.

Pharmaceutical 59

Pharmaceutical Medicine Cannabis 59

Leaf Science

DECEMBER 28, 2018

study shows that more and more people are giving up alcohol and pharmaceuticals in favour of cannabis use. are moving away from alcohol and pharmaceuticals in favour of cannabis use. A Fascinating insight into Cannabis user profiles can be found here. Medical Cannabis Over Opioids. Consumer Profiles.

Pharmaceutical 84

Pharmaceutical Data Recreational Topical 84

Cannabis Law Report

MAY 31, 2023

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) has passed a significant milestone, delivering the first doses of its CannEpil® units to patients in the United Kingdom, paving the way for the treatment of refractory epilepsy, an unmet need in the country.

Epilepsy 52

Epilepsy Pharmaceutical Treatment Patients 52

Cannabis Law Report

MAY 6, 2021

AUSTIN, Texas–(BUSINESS WIRE)–Anebulo Pharmaceuticals, Inc. Nasdaq: ANEB) (“Anebulo” or the “Company”), a clinical-stage biotechnology company developing novel solutions for people… Read More.

Pharmaceutical 59

Pharmaceutical Business 59

Cannabis Law Report

JUNE 23, 2021

COPENHAGEN , June 22, 2021 /PRNewswire/ — Valcon Medical A/S (“Valcon Medical” or the “Company”), Denmark’s leading independent cannabis concentrate and medical formulation provider, received its licensing for the commercial production of cannabis from the Danish Medicines Agency (DKMA) earlier in May 2021.

Pharmaceutical 86

Pharmaceutical Concentrates Extraction Medicine 86

Cannabis Law Report

AUGUST 10, 2021

This authorisation for TSC, represents the fourth approved indication of a cannabis-based medicine in the UK for GW and underlines GW’s commitment to the UK and regulatory approved cannabis-based medicines. “We GW’s pioneering work has led to the regulatory approval of world first, potentially life changing, cannabis-based medicines.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

JANUARY 18, 2023

UK-based Celadon Pharmaceuticals PLC received the green light to produce high-THC medicinal cannabis in its Midlands facility, reported London South East.

Pharmaceutical 52

Pharmaceutical Medicine THC Extraction 52

Cannabis Law Report

JANUARY 6, 2022

AUSTIN, Texas–(BUSINESS WIRE)– Anebulo Pharmaceuticals, Inc. About Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Anebulo Pharmaceuticals, Inc. Wainwright BioConnect Virtual Conference being held January 10-13, 2022. Eastern time on the Investors section of Anebulo’s website. Scott Anderson.

Pharmaceutical 52

Pharmaceutical Clinical Trials Cannabinoids Business 52

SpeedWeed

AUGUST 16, 2021

Healthcare & Pharmaceuticals U.S. cannabis firm PharmaCann plans IPO as New York weed legalization lifts demand -sources – Cannabis Business Executive – Cannabis and Marijuana industry news. The post Healthcare & Pharmaceuticals U.S. View original article.

Pharmaceutical 52

Pharmaceutical Business Legalization Cannabis 52

Cannabis Law Report

JULY 7, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. About MyMD Pharmaceuticals, Inc. MyMD is a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms. Eurofins is a global leader in food, environment, and pharmaceutical product testing.

Pharmaceutical 105

Pharmaceutical Data Clinical Trials Research and Development 105

Cannabis Law Report

DECEMBER 3, 2020

3, 2020 /PRNewswire/ — Pure Jamaican Limited , provider of pharmaceutical cannabinoids, genetics and consumer packaged goods products in large volumes for … Read More. MIAMI , Dec.

Pharmaceutical 64

Pharmaceutical Legislation Packaging Cannabinoids 64

Veriheal

AUGUST 12, 2021

Funded by Realm of Caring —a non-profit organization committed to redefining cannabis through research and education—this study on CBD and epilepsy was carried out as part of a joint effort with Johns Hopkins University School of Medicine researchers. 10 mg/kg/day is the current recommended maintenance dose for pharmaceutical CBD).”.

Epilepsy 81

Epilepsy Pharmaceutical Patients Sleep 81

Cannabis Law Report

APRIL 28, 2021

Poster presentation to address the preclinical cannabidiol derivative for the potential treatment of psychiatric disorders BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. Nasdaq:… Read More.

Pharmaceutical 98

Pharmaceutical Data Medicine Treatment 98

Cannabis Law Report

AUGUST 22, 2021

. “Looking at the industry as it is growing, we are seeing the emergence of a brand-new sector: the psycheceutical industry, which merges the best of psychedelics and the best of pharmaceuticals. is using cutting-edge delivery technologies to develop safe and effective psychedelic pharmaceutical medicines. Psycheceutical, Inc.

Pharmaceutical 98

Pharmaceutical Medicine Research and Development Therapy 98

Cannabis Law Report

JUNE 28, 2020

The mycology-focused company has signed an agreement with Applied Pharmaceutical Innovation (API), … Read More. Mydecine ( MYCO.CN ) ( NLBIF ) is quickly upping its fungi authority.

Pharmaceutical 59

Pharmaceutical Business Law 59

Cannabis Law Report

NOVEMBER 10, 2019

Europe Cannabis and Pain Management Devices on Cancer Pain Market Report 2019 is dispensed after a thorough study of various key market segments such as market size, latest trends, market threats and key drivers driving the Europe Cannabis and Pain Management Devices on Cancer Pain market. UNIMED PHARMACEUTICALS.

Pharmaceutical 45

Pharmaceutical Research and Development Data Business 45

Cannabis Life Network

OCTOBER 8, 2019

Dissolve Strips ™ (sublingual cannabis wafers) Now Available to Aurora’s Canadian Medical Patients NYSE | TSX: ACB OTC: CTTH EDMONTON and HAMILTON, ON, Oct. The post Aurora Cannabis and CTT Pharmaceutical Launch Sublingual Cannabis Wafers appeared first on Cannabis News | Lifestyle Tips | Expert Opinions | Stocks.

Pharmaceutical 40

Pharmaceutical Cannabis Patients Business 40